The Maharashtra Food and Drug Administration (FDA) has seized stocks of a medicine that makes misleading claim to cure diabetes after raiding the premises of a pharma distributor, FDA officials said on Wednesday.
Assistant Commissioner of FDA RP Chaudhari said drugs inspectors from the agency raided the premises of the distributor at Dombivli on Tuesday on a tip-off and seized stocks worth Rs 25,000 of Amrit Noni D-plus, a medicine whose manufacturer makes unverified claims on its label about curing diabetes.
The action was taken under the Drugs and Magic Remedies (objectionable advertisement) Act, 1954, he said.
The content of the label on Amrit Noni D-plus contravenes the provisions of the Act, the FDA official said, adding further investigation was underway.
"One cannot make claims for curing certain health disorders. Making such claims amount to violation of regulations," Mr Chaudhari said.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Northeast's Biggest Insurgent Group NSCN(IM) Threatens To End 27-Year-Old Ceasefire If 3rd-Party Intervention Not Possible "Wanted To Be A Militant After Torture By Army Officer," Claims National Conference MLA Poll Panel's Warning Amid Row Over Arvind Sawant's Shaina NC Comment Trump's Immigration Curbs To Impact Millions Of Indians, Their Children Video: Jimmy Kimmel Chokes Up During TV Show Monologue About Trump Win Elon Musk Replies To 'We Need Your Help Removing Trudeau' Post Trump Asks Musk To Join Call With Zelensky In Big Hint At His Possible Role US Judge Pauses Trump 2020 Election Case After His Big Victory Allahbad High Court Declares 2004 "Wedding" Of Minors "Void" Track Latest News Live on NDTV.com and get news updates from India and around the world.